Results 21 to 30 of about 3,164,975 (245)
Hepatology, EarlyView., 2022 Steatotic HCC can be diagnosed by MRI and forms a pro‐tumor immune microenvironment with high expression of PD‐L1, M2 polarization of macrophages and activation of CAFs, which may be a good target for combined immunotherapy. Abstract Background and Aims Immunotherapy has become the standard‐of‐care treatment for hepatocellular carcinoma (HCC), but its ...
Hiroki Murai +29 more
wiley +1 more source
Frequency of active HCV infection among anti-HCV positive patients in selected districts of Khyber Pakhtunkhwa, Pakistan [PDF]
Journal of Microbiology and Infectious Diseases, 2013 Objective: The objective of this study was to determine frequency of active HCV infection among confirmed anti-HCV positive subjects of KPK in order to help the infected subjects decide about anti-viral treatment options.Methods: Blood samples (3075 ...
Sajid Ali +3 more
doaj +2 more sources
BMC Infectious Diseases, 2018 BackgroundIncreasing the proportion diagnosed with and on treatment for chronic hepatitis C (CHC) is key to the elimination of hepatitis C in Europe. This study contributes to secondary prevention planning in the European Union/European Economic Area (EU/
A. Falla +4 more
semanticscholar +1 more source
Identification of novel neutralizing determinants for protection against HCV
Hepatology, EarlyView., 2022 Identification of novel neutralizing determinants for protection against hepatitis C virus. Abstract Background and Aims HCV evasion of neutralizing antibodies (nAb) results in viral persistence and poses challenges to the development of an urgently needed vaccine.
Garazi P. Alzua +12 more
wiley +1 more source
Prenatal hepatitis C screening, diagnoses, and follow-up testing in British Columbia, 2008-2019.
PLoS ONE, 2020 ObjectiveCurrent guidelines in British Columbia recommend prenatal screening for hepatitis C antibodies (anti-HCV) if risk factors are present. We aimed to estimate frequency of prenatal anti-HCV testing, new diagnoses, repeated and follow-up testing ...
Margo E Pearce +15 more
doaj +1 more source
Virology Journal, 2021 Background All commercial Hepatitis C virus antibody (anti-HCV) assays use a combination of recombinant antigens to detect antibody response. Antibody responses to individual antigenic regions (core, NS3/4 and NS5) used in assays have not been ...
Xinyi Jiang +6 more
doaj +1 more source
Global Journal of Transfusion Medicine, 2019 Introduction: Hepatitis C has emerged as a fatal epidemic in the country in the past two decades. One of the major risk factors remains unsafe blood transfusions.
Usman Waheed +8 more
doaj +1 more source
Scientific Reports, 2021 The spreading of viral hepatitis among injecting drug users (IDU) is an emerging public health concern. This study explored the prevalence and the risks of hepatitis B virus (HBV), hepatitis C virus (HCV) and hepatitis D virus (HDV) among IDU-dominant ...
Ming-Ying Lu +26 more
doaj +1 more source
Evaluation of a New Anti-HCV-Assay Kit for Anti-HCV Screening in Early Childhood.
The Tohoku Journal of Experimental Medicine, 1999 Sera of 20 children falsely identified as positive for hepatitis C virus antibody (Anti-HCV) by a second generation anti-HCV-assay kit (Imucheck-HCV Ab "Kokusai") were re-tested using a new third generation anti-HCV-assay kit (Imucheck x F-HCV C50 Ab "Kokusai").
Sugiyama, Kohachiro +8 more
openaire +3 more sources
Comparison of HCV core antigen and anti-HCV with HCV RNA results.
African Health Sciences, 2015 BACKGROUND The measurement of anti-HCV antibodies using immunological methods and the confirmation of viral nuclear acid based on molecular methods is important in diagnosis and follow-up of the HCV infection.
Cicioğlu Arıdoğan Buket +4 more
semanticscholar +1 more source